Deoxycholic Acid Promotes Pyroptosis in Free Fatty Acid-Induced Steatotic Hepatocytes by Inhibiting PINK1-Mediated Mitophagy

被引:0
作者
Xuebin Gao
Yongdui Ruan
Xuan Zhu
Xiaozhuan Lin
Yan Xin
Xiang Li
Meiqing Mai
Honghui Guo
机构
[1] Guangdong Medical University,Department of Nutrition, School of Public Health
[2] the First Dongguan Affiliated Hospital,Department of Traditional Chinese Medicine
[3] Guangdong Medical University,Dongguan Key Laboratory of Environmental Medicine
[4] Guangdong Medical University,undefined
来源
Inflammation | 2022年 / 45卷
关键词
deoxycholic acid; pyroptosis; NLRP3 inflammasome; mitophagy; nonalcoholic steatohepatitis.;
D O I
暂无
中图分类号
学科分类号
摘要
Nonalcoholic steatohepatitis (NASH) is the inflammatory subtype of nonalcoholic fatty liver disease (NAFLD), which can lead to liver fibrosis and cirrhosis. Bile acid levels are correlated with markers of hepatic injury in NASH, suggesting a possible role for bile acids in the progression of NAFLD. Here, we examined the role of deoxycholic acid (DCA) in driving steatotic hepatocytes to pyroptosis, a pro-inflammatory form of programmed cell death. HepG2 cells were stimulated with odium oleate and sodium palmitate for modeling steatotic hepatocytes and then treated with DCA alone or in combination with a specific mitophagy agonist, carbonyl cyanide 3-chlorophenylhydrazone (CCCP). Our results showed that DCA dose-dependently induced a pro-inflammatory response in steatotic hepatocytes but had no significant effect on lipid accumulation. Moreover, activation of the NLRP3 inflammasome and pyroptosis were triggered by DCA. Expression levels of the mitophagy markers PTEN-induced kinase 1 (PINK1) and E3 ubiquitin ligase Parkin were significantly diminished by DCA, whereas induction of mitophagy by CCCP prevented DCA-induced inflammatory response and restored the pyroptosis. Collectively, our data showed that DCA-induced pyroptosis involves the inhibition of PINK1-mediated mitophagy and the activation of the NLRP3 inflammasome. These findings provide insight into the association of DCA with mitophagy, pyroptosis, and inflammation in NASH.
引用
收藏
页码:639 / 650
页数:11
相关论文
共 290 条
[1]  
Younossi Z(2019)Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis Hepatology 69 2672-2682
[2]  
Tacke F(2020)Targeting the alternative bile acid synthetic pathway for metabolic diseases Protein & Cell 12 411-425
[3]  
Arrese M(2015)Changes in bile acid profile after laparoscopic sleeve gastrectomy are associated with improvements in metabolic profile and fatty liver disease Obesity Surgery 26 1195-1202
[4]  
Chander Sharma B(2019)Circulating bile acid profiles in Japanese patients with NASH Gastroenterology and Hepatology 1 302-310
[5]  
Mostafa I(2008)Targeting bile-acid signalling for metabolic diseases Nature Reviews Drug Discovery 7 678-693
[6]  
Bugianesi E(2008)Bile acid levels are increased in the liver of patients with steatohepatitis European Journal of Gastroenterology and Hepatology 20 519-525
[7]  
Wai-Sun Wong V(2020)Bile acid changes associated with liver fibrosis and steatosis in the Mexican-American population of South Texas Hepatology Communications 4 555-568
[8]  
Yilmaz Y(2018)The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids Hepatology 67 534-548
[9]  
George J(2017)Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: A potential role for bile acids Journal of Lipid Research 58 1399-1416
[10]  
Fan J(2016)Innate immunity and inflammation in NAFLD/NASH Digestive Diseases and Sciences 61 1294-1303